I don't think investors need to be reminded on the very day...

I don't think investors need to be reminded on the very day PTX-100 interim readout is delivered of the inherent risks of being a biotech...You don't need to tell a rock climber how gravity works when they reach a summit...Good thing we have lots of ropes.

The marketing is just another important piece to the holistic puzzle.

It's about taking potential partners and investors with PTX along for the journey.

Over the years, the presentations and articles will accumulate. The biotech community will have watched, heard PTX grow with each milestone.

It's much easier for potential partners to strike deals with companies that they trust and are familiar with over long relationships, in addition to having the right IP and data.

Every now and then you will hear a poster say, long time PTX fan and first time investor. They have grown in confidence as PTX has grown, to the point they were comfortable with taking a financial stake in the company.

A good footballer body is not built with one good pre-season...It's built over many pre-seasons of hard work and statistical data.

Just enjoy today's PTX-100 data...No one is saying it doesn't remain to have inherent risks (no more than any other biotech trial)...It's just another step in the right direction, promising but lot's of work to be done.

PTX is well capitalised, with a diversified portfolio and pipeline giving shareholders every opportunity for success...Let's enjoy the good days like today when we have them, then put the focus back on a long journey of building solid data and progressing multiple programs towards commercialisation.

Cheers.